The Blood Grouping Reagents market in Lithuania is valued at 1.2952 million USD in 2023, showcasing a gradual decline over the past decade. Since 2013, the market has observed fluctuations, with a notable decrease from the peak in 2014. In recent years, a consistent year-on-year decline of approximately 1.82% is observed, with a Compound Annual Growth Rate (CAGR) of -1.82% over the last five years, indicating a downward trend in market value and demand.
Future trends to watch for include:
- Advancements in blood grouping technologies and innovations that may reignite market growth.
- Potential increase in demand driven by healthcare reforms and the expansion of diagnostic facilities.
- Geopolitical or economic changes that may affect the healthcare sector and impact reagent consumption.
How does Lithuania rank in Blood Grouping Reagents Market Size Value?
| # | 16 Countries | US Dollars | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 China | 352,470,000 | 2023 | +3.9% | +3.83% | View data |
| 2 | 2 United Kingdom | 110,710,000 | 2023 | +1.38% | +3.83% | View data |
| 3 | 3 Spain | 103,550,000 | 2023 | +3.37% | +4.68% | View data |
| 4 | 4 Italy | 95,043,000 | 2023 | +1.51% | +1.53% | View data |
| 5 | 5 Brazil | 35,183,000 | 2023 | -3.18% | -3.78% | View data |
| 14 | 14 Denmark | 3,569,200 | 2023 | -2.29% | -3.12% | View data |
| 15 | 15 Slovenia | 3,044,600 | 2023 | -1.97% | -2.15% | View data |
| 16 | 16 Lithuania | 1,295,200 | 2023 | -1.82% | -1.82% | |
